Checkpoint Therapeutics, Inc. (CKPT): Price and Financial Metrics
CKPT Price/Volume Stats
Current price | $3.31 | 52-week high | $4.50 |
Prev. close | $3.46 | 52-week low | $1.38 |
Day low | $3.21 | Volume | 732,900 |
Day high | $3.39 | Avg. volume | 866,083 |
50-day MA | $3.41 | Dividend yield | N/A |
200-day MA | $2.69 | Market Cap | 161.64M |
CKPT Stock Price Chart Interactive Chart >
Checkpoint Therapeutics, Inc. (CKPT) Company Bio
Checkpoint Therapeutics, Inc., an immuno-oncology biopharmaceutical company, focuses on the acquisition, development, and commercialization of non-chemotherapy and immune-enhanced combination treatments for patients with solid tumor cancers. The company was founded in 2014 and is based in New York, New York. Checkpoint Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.
CKPT Price Returns
1-mo | 4.09% |
3-mo | -2.07% |
6-mo | 43.91% |
1-year | N/A |
3-year | -83.11% |
5-year | -85.61% |
YTD | 3.44% |
2024 | 39.74% |
2023 | -55.19% |
2022 | -83.57% |
2021 | 17.36% |
2020 | 54.07% |
Continue Researching CKPT
Here are a few links from around the web to help you further your research on Checkpoint Therapeutics Inc's stock as an investment opportunity:Checkpoint Therapeutics Inc (CKPT) Stock Price | Nasdaq
Checkpoint Therapeutics Inc (CKPT) Stock Quote, History and News - Yahoo Finance
Checkpoint Therapeutics Inc (CKPT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...